Segments of the ospA gene of Borrelia burgdorferi were amplified by the polymerase chain reaction (PCR). Oligonucleotide primers used in the reaction flank a 309-base-pair segment within the ospA gene. After 35 cycles of amplification, the product could be detected by agarose gel electrophoresis or dot hybridization with a 32P-labeled probe. This segment was amplified in all strains of B. burgdorferi tested, but it was not detected in other bacterial species. An additional primer pair which has a broad specificity for conserved 16S rRNA sequences that are present in eubacteria amplified a 215-base-pair fragment in all organisms tested. The sensitivity of PCR for the detection of B. burgdorferi in clinical samples was evaluated by seeding blood and urine specimens with B. burgdorferi and subjecting them to amplification. We were able to detect 10 organisms per ml of blood or urine, using PCR with dot hybridization detection. DNA extraction is not required for sample preparation. Blood and urine specimens were obtained from canines with clinical and serologic evidence of Lyme disease and subjected to PCR analysis. Of 17 clinical specimens from 15 animals, one blood specimen showed reactivity in the PCR.
Borrelia burgdorferi, the causative agent of Lyme disease, was first isolated from ticks (10) and subsequently from humans (34) , rodents (1, 2) , and some wild and domestic animals (9, 11) . The organism is transmitted to humans and animals by infected Ixodes ticks (10) . The white-tailed deer is the primary reservoir of the adult tick, and the whitefooted mouse, Peromyscus leucopus, serves as one of the primary reservoirs for the larval form (23) .
Infection in humans and some domestic animals leads to one or more of a variety of manifestations, including dermatopathy, cardiopathy, neuropathy, and arthropathy (28, 35) . Since the spirochete has been identified in clinical specimens from infected tissues and body fluids (7, 35) , these manifestations are presumed to result, at least partially, from virulence factors of the persisting spirochete in the infected organ. However, it is relatively difficult to demonstrate the presence of the spirochete in infected tissues (34) . Animal experiments have shown that spirochetes can be recovered from blood up to 2 weeks after infection (21) . However, the presence of spirochetes in heart blood several months after infection (15) and the apparent hematogenous spread of infection suggest a long-term, and perhaps intermittent, spirochetemia. The inability to recover spirochetes from blood and affected organs routinely may be due to a paucity of organisms present in infected material. Some investigators have successfully demonstrated spirochetes directly by microscopic examination of blood and urine specimens from infected animals (9, 24, 32 (31) , and a number of human DNA sequences for the diagnosis of genetic and malignant disorders (17, 18) . Recently, Olive (27) reported the detection of enterotoxigenic Escherichia coli in partially purified human stool specimens using PCR.
In the present study, the detection of a sequence within the outer membrane protein gene (ospA) (16) 12 ,800 x g for 8 min. The resulting supernatant was decanted, and the pellet was washed twice with 1 ml of filtered PBS. The pellet was suspended in 100 pl of filter-sterilized distilled water and boiled for 10 min. PCR was carried out with 10 ,u of the boiled suspension.
(ii) Blood. A 4-day-old culture of B. burgdorferi B31 (108 cells per ml in BSK II medium) was serially diluted (10-fold) in EDTA-anticoagulated whole blood. The tubes were centrifuged at 800 x g for 15 min, and 1 ml of plasma was removed. The plasma was centrifuged at 12,800 x g for 8 min, the supernatant was decanted, and the pellet was washed twice with filtered PBS. The pellet was suspended in 100 ,ul of sterile filtered distilled water and boiled for 10 min. The PCR was performed with 10 ,ul of the boiled suspension.
(iii) Urine. Urine was seeded with B. burgdorferi B31; and tubes were centrifuged at 12,800 x g, washed, and boiled, following the same procedure described above for blood.
The PCR was performed with 10 ,ul of the boiled suspension.
(iv) Clinical specimens. Blood and urine specimens were obtained from 15 canines that had clinical and serological evidence of Lyme disease and 5 normal, healthy canines. Specimens were prepared for PCR analysis as described above.
Immunofluorescence assay (IFA). Slides coated with B. burgdorferi whole-cell antigen were obtained from Bion, (8) . We chose to amplify a segment of the ospA gene because this gene may be unique to B. burgdorferi, based on DNA probe hybridization studies (6), and is widely expressed among various strains of B. burgdorferi that have been studied by other investigators (3, 6, 8) .
The oligonucleotide primers ospA, and ospA2 ( Fig. 1) span a 309-base-pair (bp) sequence within the ospA gene. These primers were used to amplify the ospA sequence in purified plasmid DNA from strain B31. The 309-bp amplification product (Fig. 1) hybridized with the 49-kilobase B. burgdorferi plasmid (Fig. 2) , which is known to be the location of the ospA gene (3) . This confirmed the expected amplification.
Specificity of amplification. To determine the specificity of the oligonucleotide primers for B. burgdorferi, a number of pathogenic organisms were tested for their reactivities in the PCR. An additional primer pair which has broad specificity for conserved 16S rRNA sequences that are present in eubacteria (12) (Fig. 1) was used as an amplification control. This primer pair amplifies a 215-bp fragment. The broadly specific primers gave rise to a 215-bp DNA fragment in all organisms tested, while ospA, and ospA2 amplified a 309-bp fragment only in strains of B. burgdorferi (Fig. 3) .
Sensitivity of PCR and dot hybridization detection. To evaluate the sensitivity of PCR, human blood and urine specimens were seeded with B. burgdorferi and subjected to amplification. By using dot hybridization to detect amplification products, 10 organisms per ml of blood or urine could be detected. Results of these experiments are shown in Fig.  4 .
Serological analysis. A total of 308 clinical canine specimens which were submitted for serological testing for Lyme disease were evaluated by IFA. Of these 308 serum specimens 76 were reactive in the IFA with titers ranging from 1:64 to 1:16,384.
PCR analysis of clinical samples. Clinical specimens from 15 canines which were diagnosed as having Lyme disease were chosen for PCR analysis on the basis of clinical symptoms and serology (IFA titer, greater than 1:64). Whole blood from 15 canines and two urine specimens were obtained and analyzed by PCR. One blood specimen from an animal with an IFA titer of 1:4,196 was found to be positive (Fig. 5) . This result was confirmed by Southern blot analysis (data not shown). All other specimens were negative in the PCR. 
DISCUSSION
Lyme disease is now the most common tick-borne infection in the United States and Europe (13, 33) . The 1 and 2) . Size markers are 32P-labeled lambda DNA (48.5 kilobases) (lanes 3) and lambda DNA HindII digest fragments (lanes 4; molecular sizes are noted on the right in kilobases). The highly sensitive and specific DNA amplification system is potentially an excellent tool for the identification of the Lyme disease agent in clinical samples as well as in vectors and animal reservoirs. This system is being applied widely to the detection of pathogens in blood and body fluids, as well as in tissue samples. We were able to detect 10 organisms per ml of seeded blood or urine using the PCR followed by dot hybridization detection of amplification products. DNA extraction is unnecessary, as the inhibitory effects of constituents such as hemoglobin are removed by a simple washing step. This represents a 100-fold increase in sensitivity over that obtained with unwashed samples (data not shown). An additional advantage of this technique is that spirochetes do not have to be viable; therefore, stored specimens can be tested easily. The high degree of specificity of PCR results from the fact that two oligonucleotide sequences must hybridize to the target DNA under stringent conditions in order for amplification to occur. The resulting amplified product must then hybridize to the ospA probe. Other species of Borrelia which have been shown to possess up to 59% DNA homology with B. burgdorferi (20) did not show reactivity with our ospA primers in the PCR.
Our finding that most of the canine blood and urine specimens were negative may be a result of the stage of disease in these subjects. These animals were infected for a sufficient length of time to develop an immune response and to exhibit symptoms. The PCR may prove to be more useful in detecting the presence of the organism in the very early stages after infection, when there is a greater likelihood of spirochetemia. This technique could also be highly useful in confirming Lyme disease since it could readily be applied to the detection of the spirochete in cerebrospinal fluid, synovial fluid, and tissue from skin lesions. The protocol de- scribed here eliminates the need for DNA extraction and thus is adaptable to epidemiological investigations such as the identification of B. burgdorferi in infected material from arthropod vectors and animals as well as B. burgdorferi isolates cultured from infected specimens.
